Bupropion sustained release:
side effect profile
by
Settle EC Jr
Department of Psychiatry,
West Virginia University,
Charleston, USA.
J Clin Psychiatry 1998; 59 Suppl 4:32-6

ABSTRACT

Bupropion IR (immediate release) has been on the market since 1988 and is an effective and usually well-tolerated antidepressant. In late 1996, a new sustained-release formulation, bupropion SR, was approved and is now available. Compared with the IR formulation, the SR formulation demonstrates similar efficacy and has been found to have similar, but to some degree fewer, side effects. Its efficacy is similar to that of other newer antidepressants. Side effects of bupropion SR are limited and are not dissimilar to those of the serotonergic antidepressants; however, bupropion SR produces neither substantial sexual side effects nor drug interactions. Study data demonstrate that seizure incidence, which is a concern with high-dose IR, is substantially lower with the new SR formulation.

Zyban
Bupropion
Bupropion and sex
Bupropion and REM
Bupropion overdose
Bupropion and seizures
Bupropion for dysthymia
Bupropion versus paroxetine
Bupropion and its metabolites
Bupropion for nicotine quitters
Bupropion used to augment SSRIs
Switching to bupropion from a SSRI
Bupropion and the dopamine transporter
Bupropion (Zyban): prescribing information (PDF)
Bupropion (Wellbutrin) for major depressive disorder
Bupropion (Wellbutrin): prescribing information (PDF)

Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family